Natixis Advisors
ATRC icon

Natixis Advisors’s AtriCure ATRC Stock Holding History

Natixis Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
+11,169
New +$314K ﹤0.01% 1777
2021
Q3 		– Sell
-12,916
Closed -$1.02M – 1311
2021
Q2 		$1.02M Buy
+12,916
New +$939K ﹤0.01% 1089

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Natixis Advisors's ATRC Position: Q2 2026 in Review

Natixis Advisors opened a new position in AtriCure (ATRC) in Q2 2026: 11,169 shares worth $312K. The stake represents ﹤0.01% of the portfolio and ranks #1777 among its holdings. This is a return to the name: Natixis Advisors previously reported a position in ATRC as recently as Q2 2021.

Natixis Advisors first reported a position in ATRC in Q2 2021 and has held it in 2 quarters since. The position peaked at $1.02M in Q2 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Natixis Advisors held 11,169 shares of AtriCure worth $312K as of Q2 2026.
  • AtriCure was a new Natixis Advisors position in Q2 2026.
  • AtriCure made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1777 holding.
  • Natixis Advisors first reported a position in AtriCure in Q2 2021 and has held it in 2 quarters since.
  • Natixis Advisors's AtriCure position peaked at $1.02M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.